Oncology Institute (DFPH) Receivables (2020 - 2025)
Historic Receivables for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to $60.0 million.
- Oncology Institute's Receivables rose 932.92% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year increase of 932.92%. This contributed to the annual value of $48.7 million for FY2024, which is 1344.64% up from last year.
- Per Oncology Institute's latest filing, its Receivables stood at $60.0 million for Q3 2025, which was up 932.92% from $55.9 million recorded in Q2 2025.
- Oncology Institute's 5-year Receivables high stood at $60.0 million for Q3 2025, and its period low was $21.2 million during Q4 2021.
- In the last 5 years, Oncology Institute's Receivables had a median value of $47.8 million in 2023 and averaged $45.0 million.
- Per our database at Business Quant, Oncology Institute's Receivables surged by 9032.67% in 2022 and then plummeted by 1600.26% in 2025.
- Over the past 5 years, Oncology Institute's Receivables (Quarter) stood at $21.2 million in 2021, then skyrocketed by 90.33% to $40.4 million in 2022, then rose by 6.13% to $42.9 million in 2023, then rose by 13.45% to $48.7 million in 2024, then rose by 23.21% to $60.0 million in 2025.
- Its Receivables stands at $60.0 million for Q3 2025, versus $55.9 million for Q2 2025 and $49.7 million for Q1 2025.